Singh SR - Search Results

1

Targeting tumor microenvironment in cancer therapy.

Singh SR, Rameshwar P, Siegel P. Singh SR, et al. Cancer Lett. 2016 Sep 28;380(1):203-4. doi: 10.1016/j.canlet.2016.04.009. Epub 2016 Apr 7. Cancer Lett. 2016. PMID: 27060765 No abstract available.

2

Cancer metabolism: targeting metabolic pathways in cancer therapy.

Singh SR, Tan M, Rameshwar P. Singh SR, et al. Cancer Lett. 2015 Jan 28;356(2 Pt A):147-8. doi: 10.1016/j.canlet.2014.06.002. Epub 2014 Jun 21. Cancer Lett. 2015. PMID: 24956174 No abstract available.

3

Featuring the guest editors: Special issue tumor microenvironment.

Singh SR, Rameshwar P, Siegel P. Singh SR, et al. Cancer Lett. 2016 Sep 28;380(1):201-2. doi: 10.1016/j.canlet.2015.05.021. Epub 2015 May 28. Cancer Lett. 2016. PMID: 26028171 No abstract available.

4

Gastric cancer stem cells: a novel therapeutic target.

Singh SR. Singh SR. Cancer Lett. 2013 Sep 10;338(1):110-9. doi: 10.1016/j.canlet.2013.03.035. Epub 2013 Apr 10. Cancer Lett. 2013. PMID: 23583679 Free PMC article. Review.

5

Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.

Seol HS, Lee SE, Song JS, Lee HY, Park S, Kim I, Singh SR, Chang S, Jang SJ. Seol HS, et al. Among authors: singh sr. Cancer Lett. 2016 Nov 28;382(2):157-165. doi: 10.1016/j.canlet.2016.08.028. Epub 2016 Sep 6. Cancer Lett. 2016. PMID: 27612558

6

The emerging roles of microRNAs in cancer metabolism.

Chan B, Manley J, Lee J, Singh SR. Chan B, et al. Among authors: singh sr. Cancer Lett. 2015 Jan 28;356(2 Pt A):301–8. doi: 10.1016/j.canlet.2014.10.011. Cancer Lett. 2015. PMID: 25451319 Review.

7

Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1.

Seol HS, Lee SE, Song JS, Rhee JK, Singh SR, Chang S, Jang SJ. Seol HS, et al. Among authors: singh sr. Cancer Lett. 2016 Mar 1;372(1):24-35. doi: 10.1016/j.canlet.2015.12.005. Epub 2015 Dec 23. Cancer Lett. 2016. PMID: 26723877 Free PMC article.

8

Hypoxia and hypoxia inducible factors in tumor metabolism.

Zeng W, Liu P, Pan W, Singh SR, Wei Y. Zeng W, et al. Among authors: singh sr. Cancer Lett. 2015 Jan 28;356(2 Pt A):263-7. doi: 10.1016/j.canlet.2014.01.032. Epub 2014 Feb 4. Cancer Lett. 2015. PMID: 24508030 Review.

9

Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Kiyuna T, Miyake M, Higuchi T, Oshiro H, Zhang Z, Razmjooei S, Wangsiricharoen S, Bouvet M, Singh SR, Unno M, Hoffman RM. Kawaguchi K, et al. Among authors: singh sr. Cancer Lett. 2018 Sep 28;432:251-259. doi: 10.1016/j.canlet.2018.06.016. Epub 2018 Jun 18. Cancer Lett. 2018. PMID: 29928962

10

Integrated genomic analyses identify KDM1A's role in cell proliferation via modulating E2F signaling activity and associate with poor clinical outcome in oral cancer.

Narayanan SP, Singh S, Gupta A, Yadav S, Singh SR, Shukla S. Narayanan SP, et al. Among authors: singh sr, singh s. Cancer Lett. 2015 Oct 28;367(2):162-72. doi: 10.1016/j.canlet.2015.07.022. Epub 2015 Jul 28. Cancer Lett. 2015. PMID: 26225839 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

592 results

Search Page